Conference LibraryGated
KLN-1010 · Kelonia Therapeutics · per ASGCT 2025 abstracts
Kelonia Therapeutics 主要 pipeline candidate · in vivo cell therapy 方向(per OPORD-002 §2 P1 verify list · ASGCT 2025 abstracts)。 详细 modality / target / indication 待 ROLLCELL verify (ASGCT abstract DB)。
- Type
- product
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- C
- category
- in_vivo_cell_therapy
- status
- draft
- instance_tag
- sunvax-antibody-2025
- modality
- other
- target_cell_type
- TBD
- cargo
- other
- application
- in vivo cell therapy (specifics TBD)
- development_stage
- preclinical or phase_1 (TBD)
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.